SCHEMBL6527178

SCHEMBL6527178

CCOC(Cc1ccc(OCc2csc(-c3ccc(F)c(Cl)c3)n2)cc1C)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 2/20 0.41
PPARA Q07869 9/20 0.40
PPARG P37231 6/20 0.40
PPARD Q03181 3/20 0.39
ALOX5 P09917 2/20 0.39
TP53 P04637 3/20 0.38
LMNA P02545 2/20 0.37
THRB P10828 1/20 0.37
SCN9A Q15858 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
PSEN1 P49768 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3369621 1.00 EIF4E (0.41) EIF4EPPARAPPARGPPARDALOX5
SCHEMBL3369247 0.92 PPARA (0.41) EIF4EPPARAPPARGPPARDALOX5
SCHEMBL3369875 0.91 PPARA (0.48) PPARAPPARGPPARDALOX5TP53
SCHEMBL3373870 0.91 PPARA (0.48) PPARAPPARGPPARDALOX5TP53
SCHEMBL3372523 0.89 PPARA (0.51) PPARAPPARGPPARDTP53THRB
SCHEMBL3401607 0.89 PPARA (0.51) PPARAPPARGPPARDTP53THRB
SCHEMBL3368818 0.88 PPARA (0.42) PPARAPPARGPPARDALOX5KDM4E
SCHEMBL3368894 0.87 PPARA (0.47) PPARAPPARGPPARDALOX5TP53
SCHEMBL3368890 0.87 PPARA (0.47) PPARAPPARGPPARDALOX5TP53
SCHEMBL3372464 0.86 PPARA (0.47) PPARAPPARGPPARDTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537091-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2005-06-08 EP disclosed
WO-2004020420-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2004-03-11 WO disclosed